Risk factor
Very poor trading liquidity
Profitability factor
Decent dividends
About
PT Enseval Putera Megatrading Tbk., together with its associated companies, plays a significant role in Indonesia's pharmaceutical sector, primarily through the distribution and supply of its products. The organization's business activities are structured into three principal categories: Pharmaceutical, Consumer Products, and a diversified "Others" segment. Beyond pharmaceuticals, the company is involved in the commerce of medical and laboratory instruments and associated supplies, operates healthcare clinics, provides dental and various other specialized equipment, and offers calibration services. Furthermore, its trading ventures extend to raw materials crucial for pharmaceutical production, consumable goods for hemodialysis treatment, and a range of food and beverage items. The firm also delivers comprehensive warehousing solutions, including climate-controlled environments like chiller, cool, and ambient rooms, in addition to container chiller options. Founded in 1973, the company was originally named PT Arya Gupta Cempaka, adopting its current designation, PT Enseval Putera Megatrading Tbk., in August 1993. Headquartered in East Jakarta, Indonesia, it functions as a subsidiary of PT Kalbe Farma Tbk.
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBIT